-
1
-
-
0032906981
-
Clinical pharmacokinetics of lamivudine
-
DOI 10.2165/00003088-199936010-00004
-
Johnson MA, Moore KH, Yuen GJ, Bye A, Pakes GE,. Clinical pharmacokinetics of lamivudine. Clin Pharmacokinet 1999; 36: 41-66. (Pubitemid 29056000)
-
(1999)
Clinical Pharmacokinetics
, vol.36
, Issue.1
, pp. 41-66
-
-
Johnson, M.A.1
Moore, K.H.P.2
Yuen, G.J.3
Bye, A.4
Pakes, G.E.5
-
2
-
-
35248815945
-
The effect of ABCG2 V12M, Q141K and Q126X, known functional variants in vitro, on the disposition of lamivudine
-
DOI 10.1111/j.1365-2125.2007.02944.x
-
Kim HS, Sunwoo YE, Ryu JY, et al,. The effect of ABCG2 V12M, Q141K and Q126X, known functional variants in vitro, on the disposition of lamivudine. Br J Clin Pharmacol 2007; 64: 645-654. (Pubitemid 47568815)
-
(2007)
British Journal of Clinical Pharmacology
, vol.64
, Issue.5
, pp. 645-654
-
-
Kim, H.-S.1
Sunwoo, Y.E.2
Ryu, J.Y.3
Kang, H.-J.4
Jung, H.-E.5
Song, I.-S.6
Kim, E.-Y.7
Shim, J.-C.8
Shon, J.-H.9
Shin, J.-G.10
-
3
-
-
0036162333
-
Uptake of lamivudine by rat renal brush border membrane vesicles
-
DOI 10.1211/0022357021771814
-
Takubo T, Kato T, Kinami J, Hanada K, Ogata H,. Uptake of lamivudine by rat renal brush border membrane vesicles. J Pharm Pharmacol 2002; 54: 111-117. (Pubitemid 34116230)
-
(2002)
Journal of Pharmacy and Pharmacology
, vol.54
, Issue.1
, pp. 111-117
-
-
Takubo, T.1
Kato, T.2
Kinami, J.3
Hanada, K.4
Ogata, H.5
-
4
-
-
0035125214
-
Uptake properties of lamivudine (3TC) by a continuous renal epithelial cell line
-
DOI 10.1139/cjpp-79-1-59
-
Leung S, Bendayan R,. Uptake properties of lamivudine (3TC) by a continuous renal epithelial cell line. Can J Physiol Pharmacol 2001; 79: 59-66. (Pubitemid 32147991)
-
(2001)
Canadian Journal of Physiology and Pharmacology
, vol.79
, Issue.1
, pp. 59-66
-
-
Leung, S.1
Bendayan, R.2
-
5
-
-
47949132723
-
Relevance of the organic cation transporters 1 and 2 for antiretroviral drug therapy in human immunodeficiency virus infection
-
Jung N, Lehmann C, Rubbert A, et al,. Relevance of the organic cation transporters 1 and 2 for antiretroviral drug therapy in human immunodeficiency virus infection. Drug Metab Dispos 2008; 36: 1616-1623.
-
(2008)
Drug Metab Dispos
, vol.36
, pp. 1616-1623
-
-
Jung, N.1
Lehmann, C.2
Rubbert, A.3
-
6
-
-
56149118632
-
Organic cation transporters and their pharmacokinetic and pharmacodynamic consequences
-
Choi MK, Song IS,. Organic cation transporters and their pharmacokinetic and pharmacodynamic consequences. Drug Metab Pharmacokinet 2008; 23: 243-253.
-
(2008)
Drug Metab Pharmacokinet
, vol.23
, pp. 243-253
-
-
Choi, M.K.1
Song, I.S.2
-
7
-
-
0036865724
-
Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences
-
DOI 10.1097/00008571-200211000-00002
-
Kerb R, Brinkmann U, Chatskaia N, et al,. Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences. Pharmacogenetics 2002; 12: 591-595. (Pubitemid 36005667)
-
(2002)
Pharmacogenetics
, vol.12
, Issue.8
, pp. 591-595
-
-
Kerb, R.1
Brinkmann, U.2
Chatskaia, N.3
Gorbunov, D.4
Gorboulev, V.5
Mornhinweg, E.6
Keil, A.7
Eichelbaum, M.8
Koepsell, H.9
-
8
-
-
0038184179
-
Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1
-
DOI 10.1073/pnas.0730858100
-
Shu Y, Leabman MK, Feng B, et al,. Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1. Proc Natl Acad Sci USA 2003; 100: 5902-5907. (Pubitemid 36576905)
-
(2003)
Proceedings of the National Academy of Sciences of the United States of America
, vol.100
, Issue.10
, pp. 5902-5907
-
-
Shu, Y.1
Leabman, M.K.2
Feng, B.3
Mangravite, L.M.4
Huang, C.C.5
Stryke, D.6
Kawamoto, M.7
Johns, S.J.8
DeYoung, J.9
Carlson, E.10
Ferrin, T.E.11
Herskowitz, I.12
Giacomini, K.M.13
Benet, L.Z.14
Brett, C.M.15
Burchard, E.G.16
Castro, R.17
-
9
-
-
0347859200
-
Novel single nucleotide polymorphisms of organic cation transporter 1 (SLC22A1) affecting transport functions
-
DOI 10.1016/j.bbrc.2003.11.175
-
Sakata T, Anzai N, Shin HJ, et al,. Novel single nucleotide polymorphisms of organic cation transporter 1 (SLC22A1) affecting transport functions. Biochem Biophys Res Commun 2004; 313: 789-793. (Pubitemid 38021900)
-
(2004)
Biochemical and Biophysical Research Communications
, vol.313
, Issue.3
, pp. 789-793
-
-
Sakata, T.1
Anzai, N.2
Shin, H.J.3
Noshiro, R.4
Hirata, T.5
Yokoyama, H.6
Kanai, Y.7
Endou, H.8
-
10
-
-
85017087382
-
Decreased function of genetic variants, Pro283Leu and Arg287Gly, in human organic cation transporter hOCT1
-
Takeuchi A, Motohashi H, Okuda M, Inui K,. Decreased function of genetic variants, Pro283Leu and Arg287Gly, in human organic cation transporter hOCT1. Drug Metab Pharmacokinet 2003; 18: 409-412.
-
(2003)
Drug Metab Pharmacokinet
, vol.18
, pp. 409-412
-
-
Takeuchi, A.1
Motohashi, H.2
Okuda, M.3
Inui, K.4
-
11
-
-
34047123147
-
Identification and functional characterization of genetic variants of human organic cation transporters in a Korean population
-
Kang HJ, Song IS, Shin HJ, et al,. Identification and functional characterization of genetic variants of human organic cation transporters in a Korean population. Drug Metab Dispos 2007; 35: 667-675.
-
(2007)
Drug Metab Dispos
, vol.35
, pp. 667-675
-
-
Kang, H.J.1
Song, I.S.2
Shin, H.J.3
-
12
-
-
0036020986
-
Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function
-
DOI 10.1097/00008571-200207000-00007
-
Leabman MK, Huang CC, Kawamoto M, et al,. Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function. Pharmacogenetics 2002; 12: 395-405. (Pubitemid 34816419)
-
(2002)
Pharmacogenetics
, vol.12
, Issue.5
, pp. 395-405
-
-
Leabman, M.K.1
Huang, C.C.2
Kawamoto, M.3
Johns, S.J.4
Stryke, D.5
Ferrin, T.E.6
DeYoung, J.7
Taylor, T.8
Clark, A.G.9
Herskowitz, I.10
Giacomini, K.M.11
-
13
-
-
33645220096
-
Transport of drugs in the kidney by the human organic cation transporter, OCT2 and its genetic variants
-
Fujita T, Urban TJ, Leabman MK, Fujita K, Giacomini KM,. Transport of drugs in the kidney by the human organic cation transporter, OCT2 and its genetic variants. J Pharm Sci 2006; 95: 25-36.
-
(2006)
J Pharm Sci
, vol.95
, pp. 25-36
-
-
Fujita, T.1
Urban, T.J.2
Leabman, M.K.3
Fujita, K.4
Giacomini, K.M.5
-
14
-
-
42149127614
-
The effect of SLCO1B115 on the disposition of pravastatin and pitavastatin is substrate dependent: The contribution of transporting activity changes by SLCO1B115
-
DOI 10.1097/FPC.0b013e3282fb02a3, PII 0121301120080500000006
-
Deng JW, Song IS, Shin HJ, et al,. The effect of SLCO1B115 on the disposition of pravastatin and pitavastatin is substrate dependent: the contribution of transporting activity changes by SLCO1B115. Pharmacogenet Genomics 2008; 18: 424-433. (Pubitemid 351535943)
-
(2008)
Pharmacogenetics and Genomics
, vol.18
, Issue.5
, pp. 424-433
-
-
Deng, J.W.1
Song, I.-S.2
Shin, H.J.3
Yeo, C.-W.4
Cho, D.-Y.5
Shon, J.-H.6
Shin, J.-G.7
-
15
-
-
78650183300
-
Differential effect of genetic variants of Na(+)-taurocholate co-transporting polypeptide (NTCP) and organic anion-transporting polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitors
-
Choi MK, Shin HJ, Choi YL, Deng JW, Shin JG, Song IS,. Differential effect of genetic variants of Na(+)-taurocholate co-transporting polypeptide (NTCP) and organic anion-transporting polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitors. Xenobiotica 2011; 41: 24-34.
-
(2011)
Xenobiotica
, vol.41
, pp. 24-34
-
-
Choi, M.K.1
Shin, H.J.2
Choi, Y.L.3
Deng, J.W.4
Shin, J.G.5
Song, I.S.6
-
16
-
-
50249136652
-
Genetic variants of organic cation transporter 2 (OCT2) significantly reduce metformin uptake in oocytes
-
Song IS, Shin HJ, Shin JG,. Genetic variants of organic cation transporter 2 (OCT2) significantly reduce metformin uptake in oocytes. Xenobiotica 2008; 38: 1252-1262.
-
(2008)
Xenobiotica
, vol.38
, pp. 1252-1262
-
-
Song, I.S.1
Shin, H.J.2
Shin, J.G.3
-
17
-
-
17644411713
-
Amino acids critical for substrate affinity of rat organic cation transporter 1 line the substrate binding region in a model derived from the tertiary structure of lactose permease
-
DOI 10.1124/mol.104.008839
-
Popp C, Gorboulev V, Muller TD, Gorbunov D, Shatskaya N, Koepsell H,. Amino acids critical for substrate affinity of rat organic cation transporter 1 line the substrate binding region in a model derived from the tertiary structure of lactose permease. Mol Pharmacol 2005; 67: 1600-1611. (Pubitemid 40594159)
-
(2005)
Molecular Pharmacology
, vol.67
, Issue.5
, pp. 1600-1611
-
-
Popp, C.1
Gorboulev, V.2
Muller, T.D.3
Gorbunov, D.4
Shatskaya, N.5
Koepsell, H.6
-
18
-
-
37349126109
-
High-affinity cation binding to organic cation transporter 1 induces movement of helix 11 and blocks transport after mutations in a modeled interaction domain between two helices
-
DOI 10.1124/mol.107.040170
-
Gorbunov D, Gorboulev V, Shatskaya N, et al,. High-affinity cation binding to organic cation transporter 1 induces movement of helix 11 and blocks transport after mutations in a modeled interaction domain between two helices. Mol Pharmacol 2008; 73: 50-61. (Pubitemid 350294196)
-
(2008)
Molecular Pharmacology
, vol.73
, Issue.1
, pp. 50-61
-
-
Gorbunov, D.1
Gorboulev, V.2
Shatskaya, N.3
Mueller, T.4
Bamberg, E.5
Friedrich, T.6
Koepsell, H.7
-
20
-
-
63849083391
-
Transport of lamivudine [(-)-beta-L-2',3'-dideoxy-3'-thiacytidine] and high-affinity interaction of nucleoside reverse transcriptase inhibitors with human organic cation transporters 1, 2, and 3
-
Minuesa G, Volk C, Molina-Arcas M, et al,. Transport of lamivudine [(-)-beta-L-2',3'-dideoxy-3'-thiacytidine] and high-affinity interaction of nucleoside reverse transcriptase inhibitors with human organic cation transporters 1, 2, and 3. J Pharmacol Exp Ther 2009; 329: 252-261.
-
(2009)
J Pharmacol Exp Ther
, vol.329
, pp. 252-261
-
-
Minuesa, G.1
Volk, C.2
Molina-Arcas, M.3
-
21
-
-
78651362677
-
Substrate recognition and translocation by polyspecific organic cation transporters
-
Koepsell H,. Substrate recognition and translocation by polyspecific organic cation transporters. Biol Chem 2011; 392: 95-101.
-
(2011)
Biol Chem
, vol.392
, pp. 95-101
-
-
Koepsell, H.1
-
22
-
-
54249106729
-
Genetic variants of the organic cation transporter 2 influence the disposition of metformin
-
Song IS, Shin HJ, Shim EJ, et al,. Genetic variants of the organic cation transporter 2 influence the disposition of metformin. Clin Pharmacol Ther 2008; 84: 559-562.
-
(2008)
Clin Pharmacol Ther
, vol.84
, pp. 559-562
-
-
Song, I.S.1
Shin, H.J.2
Shim, E.J.3
-
23
-
-
33845922107
-
Cysteine accessibility in the hydrophilic cleft of human organic cation transporter 2
-
DOI 10.1074/jbc.M606561200
-
Pelis RM, Zhang X, Dangprapai Y, Wright SH,. Cysteine accessibility in the hydrophilic cleft of human organic cation transporter 2. J Biol Chem 2006; 281: 35272-35280. (Pubitemid 46036565)
-
(2006)
Journal of Biological Chemistry
, vol.281
, Issue.46
, pp. 35272-35280
-
-
Pelis, R.M.1
Zhang, X.2
Dangprapai, Y.3
Wright, S.H.4
-
24
-
-
27144555426
-
A conserved glutamate residue in transmembrane helix 10 influences substrate specificity of rabbit OCT2 (SLC22A2)
-
DOI 10.1074/jbc.M506342200
-
Zhang X, Shirahatti NV, Mahadevan D, Wright SH,. A conserved glutamate residue in transmembrane helix 10 influences substrate specificity of rabbit OCT2 (SLC22A2). J Biol Chem 2005; 280: 34813-34822. (Pubitemid 41504615)
-
(2005)
Journal of Biological Chemistry
, vol.280
, Issue.41
, pp. 34813-34822
-
-
Zhang, X.1
Shirahatti, N.V.2
Mahadevan, D.3
Wright, S.H.4
|